More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one backdated for November 24 for Daiichi Sankyo’s tenosynovial giant cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback